Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: A phase II trial

Author： Ta-Chung Chao   Zyting Chu   Ling-Ming Tseng   Tzeon-Jye Chiou   Ruey-Kuen Hsieh   Wei-Shu Wang   Chueh-Chuan Yen   Muh-Hwa Yang   Liang-Tsai Hsiao   Jin-Hwang Liu   Po-Min Chen  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.23, Iss.2, 2005-01, pp. : 171-177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anastrozole: first-line therapy for advanced breast cancer?

By  

Inpharma, Vol. 1, Iss. 1270, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer

By Madajewicz Stefan  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 772-778

Springer Publishing Company

Access to resources Recommend Favorite

Capecitabine combined with docetaxel versus vinorelbine followed by capecitabine maintenance medication for first-line treatment of patients with advanced breast cancer: Phase 3 randomized trial

By  

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3412-3421

Blackwell Publishing

Access to resources Recommend Favorite

Bevacizumab: A Review of its Use in Combination with Paclitaxel or Capecitabine as First-Line Therapy for HER2-Negative Metastatic Breast Cancer

By Croom Katherine F.   Dhillon Sohita  

Drugs, Vol. 71, Iss. 16, 2011-11 ,pp. : 2213-2229

Adis International

Access to resources Recommend Favorite

A Stochastic Economic Evaluation of Letrozole versus Tamoxifen as a First-Line Hormonal Therapy: For Advanced Breast Cancer in Postmenopausal Patients

By Karnon J.  

PharmacoEconomics, Vol. 21, Iss. 7, 2003-01 ,pp. : 513-525

Adis International

Access to resources Recommend Favorite